English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Cystic fibrosis–related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF) (1). Consensus guidelines state that all patients above the age of 10 years should be screened annually for CFRD with a 2-h 75-g oral glucose tolerance test (OGTT) (2). There are four categories of glucose tolerance based on OGTT fasting and 75-g 2-h glucose levels: normal glucose tolerance, impaired glucose tolerance (IGT) with 2 h level 7.8–11.1 mmol/L, CFRD without fasting hyperglycemia (CFRD FH−) with 2-h level > 11.1 mmol/L, and CFRD with fasting hyperglycemia (CFRD FH+) (2).At our institution in 2011, there were 167 pre–lung transplant adult CF patients, of whom 46 had preexisting CFRD. Of the remaining, 28 agreed to the test; 3 were found to have CFRD FH−, 1 was …

Hypoglycemia in Adults With Cystic Fibrosis During Oral Glucose Tolerance Testing